Inke in Numbers: When Scale Meets Precision

Each year, Inke manufactures over 30,000 kg of pharmaceutical products, reinforcing its position as a trusted partner in the development and production of high-value active pharmaceutical ingredients (APIs). This figure is not only a testament to our industrial capacity but also to our unwavering commitment to quality, innovation, and technical excellence.

Of this total, more than 9,000 kg are market-ready APIs, formulated to support therapies across global markets. These products meet the most stringent regulatory and quality standards, particularly in therapeutic areas that require exceptional precision and control.

Focused Expertise in Inhalation and CNS Therapies

What truly sets Inke apart is not just the volume we produce, but the complexity of our APIs. Our portfolio is primarily focused on inhalation therapies and central nervous system (CNS) treatments—two of the most technically demanding segments in pharmaceutical manufacturing. These areas require:

• Rigorous quality assurance
• Full regulatory compliance
• Advanced particle engineering and control

Among our most specialized outputs are 220 kg of tailor-made micronized APIs for inhalation, a segment that demands cutting-edge technology and meticulous process control. This level of specialization reflects our deep technical know-how and operational discipline.

A Global Partner in High-Precision Manufacturing

Inke’s ability to deliver at this scale and level of complexity is the result of decades of experience, continuous investment in advanced technologies, and strong, long-term collaborations with partners around the world. Our reputation is built on trust, reliability, and adaptability to the evolving needs of the pharmaceutical industry.

---

Key Figures at a Glance:

• Over 30,000 kg of pharmaceutical products manufactured annually
• Over 9,000 kg of market-ready APIs
• 220 kg of customized micronized APIs for inhalation